Dr. Michael Nanna and Dr. Gibson discuss the PRECISE trial. February 14, 2024 Disclosures: s/b HeartFlow
Dr. Harlan Krumholz shares vision for the Journal as the new Editor-in-Chief of JACC December 8, 2023
Dr. Manesh Patel and Dr. C. Michael Gibson Discuss: The early termination of the OCEANIC AF study of the Factor Xi Inhibitor Asundexian due to lack of efficacy November 30, 2023
Dr. Demilade A Adedinsewo Presents: Screening for Peripartum Cardiomyopathies Using an Artificial Intelligence Enhanced Digital Stethoscope: A Randomized Clinical Trial November 15, 2023 Disclosures: TBD
Dr. Paul Ridker and Dr. C. Michael Gibson Discuss: CLEAR OUTCOMES subanalysis on predicting CV events November 13, 2023 Disclosures: TBD
Dr. Richard Wright and Dr. C. Michael Gibson Discuss: The Genetic / Mendalian randomization (natures randomized trial) data that supports the efficacy of Acoramadis in amyloidosis and the potential for amyloid regression with therapy November 13, 2023 Disclosures: TBD
Dr. Charalambos Antoniades and Dr. C. Michael Gibson Discuss: Novel AI Technology to Improve Risk Stratification of Patients Without Obstructive Coronary Artery Disease Undergoing CCTA: The Oxford Risk Factors and Non-Invasive Imaging (ORFAN) Study November 13, 2023 Disclosures: TBD
Dr. Alexander Fanaroff Presents: A Cluster Randomized Trial of Automated Referral to Centralized Pharmacy Services for Evidence-Based Statin Initiation in High-Risk Patients November 13, 2023 Disclosures: TBD
Dr. Daniel Judge and Dr. C. Michael Gibson: Acoramidis from bench to bedside November 12, 2023 Disclosures: TBD
Dr. Steven Nissen and Dr. C. Michael Gibson Discuss: Efficacy and Safety of Lepodisiran: An Extended Duration Short-Interfering RNA Targeting Lipoprotein (a) November 12, 2023 Disclosures: TBD
